Market Closed -
NSE India S.E.
12:43:54 31/05/2024 BST
|
5-day change
|
1st Jan Change
|
632.1
INR
|
+0.29%
|
|
+2.25%
|
+47.43%
|
Fiscal Period: March |
2022
|
2023
|
---|
Capitalization
1 |
4,578
|
4,715
|
Enterprise Value (EV)
1 |
2,884
|
3,445
|
P/E ratio
|
11.3
x
|
11.4
x
|
Yield
|
1.67%
|
1.78%
|
Capitalization / Revenue
|
0.98
x
|
0.92
x
|
EV / Revenue
|
0.62
x
|
0.67
x
|
EV / EBITDA
|
5.59
x
|
5.87
x
|
EV / FCF
|
-17,215,837
x
|
-27,664,727
x
|
FCF Yield
|
-0%
|
-0%
|
Price to Book
|
1.16
x
|
1.17
x
|
Nbr of stocks (in thousands)
|
21,794
|
20,927
|
Reference price
2 |
210.0
|
225.3
|
Announcement Date
|
26/08/22
|
18/08/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
3,522
|
3,073
|
3,289
|
4,276
|
4,659
|
5,131
|
EBITDA
1 |
396.4
|
395.8
|
405.7
|
552.3
|
515.5
|
586.9
|
EBIT
1 |
237.8
|
301.4
|
322.1
|
434.1
|
402.8
|
478.7
|
Operating Margin
|
6.75%
|
9.81%
|
9.79%
|
10.15%
|
8.64%
|
9.33%
|
Earnings before Tax (EBT)
1 |
198.5
|
761.2
|
246.7
|
217.4
|
455.6
|
570.4
|
Net income
1 |
112
|
638.2
|
162.1
|
158.3
|
380.9
|
426.3
|
Net margin
|
3.18%
|
20.77%
|
4.93%
|
3.7%
|
8.17%
|
8.31%
|
EPS
2 |
6.800
|
37.65
|
8.900
|
8.695
|
18.58
|
19.70
|
Free Cash Flow
|
-
|
109.6
|
-15.56
|
-154.3
|
-167.5
|
-124.5
|
FCF margin
|
-
|
3.57%
|
-0.47%
|
-3.61%
|
-3.6%
|
-2.43%
|
FCF Conversion (EBITDA)
|
-
|
27.68%
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
17.17%
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
3.500
|
4.000
|
Announcement Date
|
17/05/21
|
17/05/21
|
17/05/21
|
30/07/21
|
26/08/22
|
18/08/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
274
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
22.5
|
117
|
219
|
1,694
|
1,270
|
Leverage (Debt/EBITDA)
|
0.6908
x
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
110
|
-15.6
|
-154
|
-168
|
-125
|
ROE (net income / shareholders' equity)
|
-
|
40.1%
|
8.04%
|
7.62%
|
12.8%
|
10.7%
|
ROA (Net income/ Total Assets)
|
-
|
6.41%
|
6.32%
|
8.55%
|
6.4%
|
5.87%
|
Assets
1 |
-
|
9,962
|
2,564
|
1,851
|
5,955
|
7,266
|
Book Value Per Share
2 |
76.90
|
117.0
|
115.0
|
109.0
|
181.0
|
192.0
|
Cash Flow per Share
2 |
4.830
|
7.980
|
10.10
|
8.750
|
0.2600
|
1.760
|
Capex
1 |
258
|
89.5
|
153
|
58.5
|
148
|
709
|
Capex / Sales
|
7.32%
|
2.91%
|
4.66%
|
1.37%
|
3.18%
|
13.82%
|
Announcement Date
|
17/05/21
|
17/05/21
|
17/05/21
|
30/07/21
|
26/08/22
|
18/08/23
|
|
1st Jan change
|
Capi.
|
---|
| +47.43% | 158M | | +40.73% | 739B | | +32.83% | 598B | | -6.42% | 353B | | +15.15% | 318B | | +4.05% | 285B | | +15.00% | 240B | | -5.52% | 206B | | +6.19% | 164B | | -0.45% | 162B |
Other Pharmaceuticals
|